Did chloroquine really fail a COVID-19 study—or was the trial design to blame?

Did chloroquine really fail a COVID-19 study—or was the trial design to blame?

Source: 
Fierce Pharma
snippet: 

News recently emerged that hydroxychloroquine—an anti-malaria drug highlighted by President Donald Trump as a promising coronavirus therapy—disappointed in a China clinical trial on mild COVID-19 patients. But a careful examination of the study reveals a more complicated situation.